[
  {
    "ts": null,
    "headline": "FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia",
    "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for MR-141 (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia. The FDA has assigned a PDUFA goal date of October 17, 2026. Presbyopia is the age-related progressive loss of the ability to focus on close objects that results in blurred near vision and eye strain. The condition affects a",
    "url": "https://finnhub.io/api/news?id=2ab74bba098597ec68119bf2c2a7e3c93ffe42aa230c8c0b5ba0f6180c963265",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772020740,
      "headline": "FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia",
      "id": 139206597,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for MR-141 (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia. The FDA has assigned a PDUFA goal date of October 17, 2026. Presbyopia is the age-related progressive loss of the ability to focus on close objects that results in blurred near vision and eye strain. The condition affects a",
      "url": "https://finnhub.io/api/news?id=2ab74bba098597ec68119bf2c2a7e3c93ffe42aa230c8c0b5ba0f6180c963265"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Says FDA Accepts For Review sNDA For MR-141 For Treatment Of Presbyopia; FDA PDUFA Goal Date Set For October 17",
    "summary": "FDA PDUFA Goal Date Set for October 17, 2026PITTSBURGH, Feb. 25, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has",
    "url": "https://finnhub.io/api/news?id=1a8f08585130559cf8a00cee3b903d8482b56c44d6d23af53073a47e180c5ce0",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772006512,
      "headline": "Viatris Says FDA Accepts For Review sNDA For MR-141 For Treatment Of Presbyopia; FDA PDUFA Goal Date Set For October 17",
      "id": 139208776,
      "image": "",
      "related": "VTRS",
      "source": "Benzinga",
      "summary": "FDA PDUFA Goal Date Set for October 17, 2026PITTSBURGH, Feb. 25, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has",
      "url": "https://finnhub.io/api/news?id=1a8f08585130559cf8a00cee3b903d8482b56c44d6d23af53073a47e180c5ce0"
    }
  },
  {
    "ts": null,
    "headline": "Earnings To Watch: Viatris (VTRS) Reports Q4 Results Tomorrow",
    "summary": "Medication company Viatris (NASDAQ:VTRS) will be announcing earnings results this Thursday before market hours. Here’s what to expect.",
    "url": "https://finnhub.io/api/news?id=2395863bc7359613399d419b1929aba3207beaeddf3e8b2bd9f8b2bf3eceb1d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771998385,
      "headline": "Earnings To Watch: Viatris (VTRS) Reports Q4 Results Tomorrow",
      "id": 139204525,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Medication company Viatris (NASDAQ:VTRS) will be announcing earnings results this Thursday before market hours. Here’s what to expect.",
      "url": "https://finnhub.io/api/news?id=2395863bc7359613399d419b1929aba3207beaeddf3e8b2bd9f8b2bf3eceb1d4"
    }
  }
]